ILMN
Illumina, Inc. · Healthcare · Medical - Diagnostics & Research
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q2 2024
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 164 | +8 | 117.28M | $20.61B | +11 | −2 |
| Q1 2026 | 158 | -5 | 113.90M | $14.03B | +5 | −11 |
| Q4 2025 | 162 | 0 | 124.91M | $16.38B | +2 | −1 |
| Q3 2025 | 23 | -1 | 78.13M | $7.41B | +1 | −3 |
| Q2 2025 | 22 | 0 | 71.58M | $6.83B | +1 | −1 |
| Q1 2025 | 19 | 0 | 39.00M | $3.09B | +1 | −1 |
| Q4 2024 | 19 | 0 | 37.37M | $4.99B | +2 | −2 |
| Q3 2024 | 18 | 0 | 20.75M | $2.70B | +1 | −1 |
| Q2 2024 | 18 | — | 22.19M | $2.32B | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 5.61M | — | $585.07M | 0.5% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 5.61M | — | $585.07M | 0.5% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 5.61M | — | $585.07M | 0.5% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 5.61M | — | $585.07M | 0.5% | n/c | 1 | SEC ↗ |
| 5 | Capital World Investors ✦ | 3.38M | — | $353.00M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 2.68M | — | $279.23M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 2.68M | — | $279.23M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | PRIMECAP Management ✦ | 2.43M | — | $253.51M | 0.2% | n/c | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (被动) | 2.08M | — | $217.38M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.49M | — | $155.07M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 1.39M | — | $144.67M | 0.4% | n/c | 1 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 1.00M | — | $104.41M | 0.2% | n/c | 1 | SEC ↗ |
| 13 | Marshall Wace ✦ | 743.70K | — | $77.63M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 743.70K | — | $77.63M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Icahn Capital ✦ | 430.00K | — | $44.88M | 0.4% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 426.30K | — | $44.50M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 426.30K | — | $44.50M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 161.09K | — | $16.81M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 161.09K | — | $16.81M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 144.41K | — | $15.07M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 112.65K | — | $11.76M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 112.65K | — | $11.76M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 75.56K | — | $7.89M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 75.56K | — | $7.89M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 75.56K | — | $7.89M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 75.56K | — | $7.89M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Wellington Management ✦ | 30.19K | — | $3.15M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Wellington Management ✦ | 30.19K | — | $3.15M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Gotham Asset Management ✦ | 12.53K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | GAMCO Investors ✦ | 2.46K | — | $257,297 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 837 持有人, 154.80M 股份, $18.58B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Director · 8.19K 股 · $1.78M
Director · 86.83K 股 · $18.98M
Director · 133.26K 股 · $29.25M
Director · 3.88K 股 · $854,765
Director · 4.53K 股 · $952,918
Director · 7.15K 股 · $1.51M
Director · 13.05K 股 · $2.78M
Director · 6.82K 股 · $1.46M
Director · 13.67K 股 · $2.93M
Director · 9.37K 股 · $2.02M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论